Malignant endometrial pathology.
Nieberg RK, Hirschowitz SL.
Curr Opin Obstet Gynecol. 1992 Aug;4(4):594-600.
M2 macrophage-secreted KYNU promotes stemness remodeling and malignant behavior in endometrial cancer via the SOD2-mtROS-ERO1alpha-UPR(ER) axis.
Pan X, Wang W, Wang Y, Gu J, Ma X.
J Exp Clin Cancer Res. 2025 Jul 4;44(1):193. doi: 10.1186/s13046-025-03285-y.
Malignant peritoneal cytology in endometrial cancer: a contemporary review.
Guo XM, Roman LD, Klar M, Wright JD, Matsuo K.
Expert Rev Anticancer Ther. 2022 Sep;22(9):947-955. doi: 10.1080/14737140.2022.2105208. Epub 2022 Jul 26.
Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium.
Perevalova AM, Kobelev VS, Sisakyan VG, Gulyaeva LF, Pustylnyak VO.
Biochemistry (Mosc). 2022 Nov;87(11):1310-1326. doi: 10.1134/S0006297922110104.
[Uterine cancer].
Isaka K, Kato R, Ito H.
Gan To Kagaku Ryoho. 2014 Nov;41(11):1354-7.
Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS, Kim NY, Min KW, Kang DW.
Medicina (Kaunas). 2023 Jul 6;59(7):1258. doi: 10.3390/medicina59071258.
[Meno-metrorrhagia imaging].
Robert Y, Bazot M.
J Radiol. 2008 Jan;89(1 Pt 2):115-33. doi: 10.1016/s0221-0363(08)70383-4.
Rare uterine cancers.
Acharya S, Hensley ML, Montag AC, Fleming GF.
Lancet Oncol. 2005 Dec;6(12):961-71. doi: 10.1016/S1470-2045(05)70463-0.
Uterine epithelioid smooth muscle tumor of uncertain malignant potential.
Gomez NF, Zhao J, Smith B.
Int J Gynecol Cancer. 2023 Aug 7;33(8):1324-1325. doi: 10.1136/ijgc-2022-004117.
PVT1/miR-136/Sox2/UPF1 axis regulates the malignant phenotypes of endometrial cancer stem cells.
Li Q, Kong F, Cong R, Ma J, Wang C, Ma X.
Cell Death Dis. 2023 Mar 3;14(3):177. doi: 10.1038/s41419-023-05651-0.
